Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C24H24FN3O2.C6H6O3S |
| Molecular Weight | 563.64 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(=O)(=O)C1=CC=CC=C1.FC2=CC=CC(CNC(=O)CC3=NC=C(C=C3)C4=CC=C(C=C4)N5CCOCC5)=C2
InChI
InChIKey=PTKRPOIHIOAMPP-UHFFFAOYSA-N
InChI=1S/C24H24FN3O2.C6H6O3S/c25-21-3-1-2-18(14-21)16-27-24(29)15-22-7-4-20(17-26-22)19-5-8-23(9-6-19)28-10-12-30-13-11-28;7-10(8,9)6-4-2-1-3-5-6/h1-9,14,17H,10-13,15-16H2,(H,27,29);1-5H,(H,7,8,9)
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma. | 2018 Dec |
|
| Discovery of Novel Dual Mechanism of Action Src Signaling and Tubulin Polymerization Inhibitors (KX2-391 and KX2-361). | 2018 Jun 14 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
413513
Created by
admin on Sat Dec 16 11:28:31 GMT 2023 , Edited by admin on Sat Dec 16 11:28:31 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
73334909
Created by
admin on Sat Dec 16 11:28:31 GMT 2023 , Edited by admin on Sat Dec 16 11:28:31 GMT 2023
|
PRIMARY | |||
|
1571072-87-1
Created by
admin on Sat Dec 16 11:28:31 GMT 2023 , Edited by admin on Sat Dec 16 11:28:31 GMT 2023
|
PRIMARY | |||
|
A718CYC1N0
Created by
admin on Sat Dec 16 11:28:31 GMT 2023 , Edited by admin on Sat Dec 16 11:28:31 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
